Tate & Lyle Ventures is a £25M venture capital fund focused on investing in high growth companies in the fields of renewable ingredients, food technologies, biomaterials and industrial processing technologies.
We believe that our insight into financing high growth businesses coupled with Tate & Lyle's expertise in bringing new products to market offers our portfolio companies unique competitive advantages in building successful independent ventures.
Appointments boost Aquapharm growth
Marine biotechnology company Aquapharm has made two major appointments to help it move closer to commercialising its assets. Jon Williams joins Aquapharm as business development director with a remit to explore non-pharmaceutical markets for its products in areas such as personal care, food, nutrition and industrial chemistry. Also signing up is Dr Lloyd Payne who becomes research director.